Literature DB >> 206445

Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma.

F Giuliani, O Bellini, A M Casazza, F Formelli, G Savi, A Di Marco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 206445     DOI： 10.1016/0014-2964(78)90260-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin.

Authors:  O Cantoni; P Sestili; F Cattabeni; C Geroni; M Grandi; F C Giuliani
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.

Authors:  F Formelli; C Pollini; A M Casazza; A di Marco; A Mariani
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 3.  The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.

Authors:  A Goldin; J M Venditti; R Geran
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.